PDF
Citation
Print
Abstract
Thirty years have passed since the Korean Association of Pediatric Allergy and Respiratory Disease was founded. There have been great changes in the pattern of respiratory diseases in Korean children during the last 30 years with economic development in the country. Pneumonia remains the leading cause of childhood morbidity, despite advances in the prevention and management. The incidence and mortality of pneumonia caused by typical bacterial pathogens have been reduced. However, the predominance of Mycoplasma pneumoniae or virus-associated diseases is emerging, which suggests that novel diagnostic and therapeutic strategies are needed. Viral bronchiolitis is one of the most substantial health burdens for infants and young children worldwide. Although respiratory syncytial virus is the most common pathogen, molecular diagnostic techniques have identified many other viruses including human rhinovirus causing bronchiolitis. Bronchiectasis is a chronic respiratory condition characterized by chronic infection, airway inflammation, and progressive lung function decline. Research into the interactions between early life respiratory infections and development of bronchiectasis is imperative to halt the disease in its origin and improve adult outcomes. Acute respiratory distress syndrome (ARDS) is a severe, life-threatening lung disease with diffuse inflammatory lung injury leading to pulmonary edema and hypoxia. Although many modalities to treat ARDS have been studied, supportive therapies and lung protective ventilator support remains the mainstay. This review focuses on the current trends in research on these childhood respiratory diseases through literature review and aims to investigate the impact of Korean study results in this field.
REFERENCES
1. The World Bank. GNI per capita, Atlas method (current US$), 2017 [Internet]. Washington, DC: The World Bank;c2018. [cited 2018 Jan 18] Available from. http://databank.worldbank.org/data/reports.aspx?source=2&series=NY.GNP.PCAP.CD&country=#.
2. Yang HJ, Song DJ, Shim JY. Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr. 2017; 60:167–74.
3. Jhang WK, Park SJ, Lee E, Yang SI, Hong SJ, Seo JH, et al. The first success-ful heart-lung transplant in a Korean child with humidifier disinfectant-associated interstitial lung disease. J Korean Med Sci. 2016; 31:817–21.
4. Lee CH, Won YK, Roh EJ, Suh DI, Chung EH. A nationwide study of children and adolescents with pneumonia who visited Emergency Department in South Korea in 2012. Korean J Pediatr. 2016; 59:132–8.
5. Korea Centers for Disease Control & Prevention. Guidelines for the an-tibiotic use in children with lower respiratory tract infections [Internet]. Osong (Korea): Korea Centers for Disease Control & Prevention;2017. [cited 2017 Sep 1]. Available from. http://cdc.go.kr/CDC/notice/CdcKrTogether0302.jsp?menuIds=HOME001-MNU1154-MNU0005-MNU0088&cid=74134.
6. Jeon YH, Kim JH. Treatment of community-acquired pneumonia in Korean children. Allergy Asthma Respir Dis. 2017; 5:177–84.
7. Revised WHO Classification and Treatment of Pneumonia in Children at Health Facilities: Evidence Summaries. Geneva: World Health Orga-nization;2014.
8. Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, et al. Brit-ish Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011; 66(Suppl 2):ii1–23.
9. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011; 53:e25–76.
10. Uehara S, Sunakawa K, Eguchi H, Ouchi K, Okada K, Kurosaki T, et al. Japanese guidelines for the management of respiratory infectious diseases in children 2007 with focus on pneumonia. Pediatr Int. 2011; 53:264–76.
11. Kim KW, Kim KE. Mycoplasma and chlamydia infection in Korea. Korean J Pediatr. 2009; 52:277–82.
12. Wy HH, Min DH, Kim DS, Park MS, Shim JW, Jung HL, et al. Clinical characteristics of Mycoplasma pneumoniae pneumonia in Korean children during the recent 3 epidemics. Allergy Asthma Respir Dis. 2017; 5:8–14.
13. Kim JW, Seo HK, Yoo EG, Park SJ, Yoon SH, Jung HY, et al. Mycoplasma pneumoniae pneumonia in Korean children, from 1979 to 2006-a metaanalysis. Korean J Pediatr. 2009; 52:315–23.
14. Shim MJ. Mycoplasma pneumonia in children. Med J Red Cross Hospital. 1980; 7:53–7.
15. Lee JK, Hong CH, Sohn YM, Kim KE, Kim DH, Kim PK, et al. Mycoplasmal pneumoniain children. Yonsei Med J. 1986; 27:300–6.
16. Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev. 2017; 30:747–809.
17. Youn YS, Lee KY, Hwang JY, Yim JW, Kang JH, Lee JS. Comparison of diagnostic methods and the changes of IgG subclasses in children with mycoplasma pneumoniae pneumonia. Pediatr Allergy Respir Dis. 2009; 19:137–45.
18. Eun BL, Park SH, Tockgo YC, Seong SC. Detection of Mycoplasma pneu-moriae in clinical samples from pediatric patients by polymerase chain reaction. J Korean Pediatr Soc. 1995; 38:1077–86.
19. Kang HW, Ahn BM, Song MY, Kim ER, Choi SH, Kim IS. The diagnostic value of polymerase chain reaction in Mycoplasma pneumoniae pneumonia. J Korean Pediatr Soc. 1998; 41:1351–8.
20. Shin YH, Lee BC, Song TW, Kim KW, Lee KE, Kim ES, et al. Diagnostic availability of PCR and ELISA in Mycoplasma pneumoniae pneumonia. pediatr Allergy Respir Dis. 2006; 16:47–56.
21. Spuesens EB, Fraaij PL, Visser EG, Hoogenboezem T, Hop WC, van Ad-richem LN, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013; 10:e1001444.
22. Nilsson AC, Björkman P, Persson K. Polymerase chain reaction is supe-rior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol. 2008; 8:93.
23. Canadian Agency for Drugs and Technologies in Health. Serum IgM and molecular tests for mycoplasma pneumoniae detection: a review of diagnostic test accuracy, clinical effectiveness, cost-effectiveness, and guidelines. Canadian Agency for Drugs and Technologies in Health. CADTH rapid response reports. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health;2015.
24. Choi J, Koh JY, Kim HB, Kim CG. The association of eosinophilic airway inflammation in Mycoplasma pneumonia and asthma. Pediatr Allergy Respir Dis. 2009; 19:63–70.
25. Kim KW, Lee BC, Lee KE, Kim ES, Song TW, Park MY, et al. Mycoplasma pneumoniae-induced production of proasthmatic mediators in airway epithelium. Korean J Pediatr. 2006; 49:977–82.
26. Yoo Y, Suh DI, Kim DK, Yu J, Koh YY, Kim CK. Association of HRCT findings suggestive of bronchiolitis obliterans with bronchial hyperresponsiveness after Mycoplasma pneumoniae pneumonia. Pediatr Allergy Respir Dis. 2004; 14:350–7.
27. Park KM, Son SK, Kim HY, Kim YW, Hwang JY, Park HJ. Clinical features of necrotizing pneumonia in children. Allergy Asthma Respir Dis. 2014; 2014:208–12.
28. Oh CE, Choi EH, Lee HJ. Detection of genetic mutations associated with macrolide resistance of Mycoplasma pneumoniae. Korean J Pediatr. 2010; 53:178–83.
29. Hong KB, Choi EH, Lee HJ, Lee SY, Cho EY, Choi JH, et al. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011. Emerg Infect Dis. 2013; 19:1281–4.
30. Seo YH, Kim JS, Seo SC, Seo WH, Yoo Y, Song DJ, et al. Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia. Korean J Pediatr. 2014; 57:186–92.
31. Lee E, Cho HJ, Hong SJ, Lee J, Sung H, Yu J. Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children. Korean J Pediatr. 2017; 60:151–7.
32. Kim JH, Kim JY, Yoo CH, Seo WH, Yoo Y, Song DJ, et al. Macrolide resistance and its impacts on M. pneumoniae pneumonia in children: comparison of two recent epidemics in Korea. Allergy Asthma Immunol Res. 2017; 9:340–6.
33. Yu J. Clinical issues regarding increased macrolide-resistant Mycoplasma pneumoniae in children. Allergy Asthma Respir Dis. 2017; 5:1–2.
34. Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr. 2012; 55:42–7.
35. Lee SY, Oh JW, Lee HB, Lee HR, Ahn KM, Lee SI. Epidemiology of childhood viral respiratory tract infections in Seoul. Pediatr Allergy Respir Dis. 1999; 9:100–8.
36. Park HY, Lee NY, Lee JS, Jung EH, Lee SJ, Ahn KM, et al. An epidemiological study of acute viral lower respiratory tract infections in hospitalized children from 1996 to 2002 in Seoul, Korea. Pediatr Allergy Respir Dis. 2003; 13:216–26.
37. Park JS. Viral etiology and epidemiology of acute lower respiratory tract infections in hospitalized children (Choongchung Province in May 2001 through April 2004). Pediatr Allergy Respir Dis. 2004; 14:366–76.
38. Cheong HY, Lee JH, Kim YB, Nam HS, Choi YJ, Kim CJ, et al. Viral eti-ologic agents in acute viral lower respiratory tract detected by multiplex RT-PCR. Pediatr Allergy Respir Dis. 2007; 17:344–53.
39. Kim JE, Bauer S, La KS, Lee KH, Choung JT, Roh KH, et al. CD4+/CD8+ T lymphocytes imbalance in children with severe 2009 pandemic influ-enza A (H1N1) pneumonia. Korean J Pediatr. 2011; 54:207–11.
40. Shin HW, Cho HL, You JH, You EJ, Kim EY, Kim KS, et al. Comparison of clinical manifestations of RSV, rhinovirus and bocavirus infections in children with acute wheezing. Pediatr Allergy Respir Dis. 2011; 21:334–43.
41. Schroeder AR, Ralston SL. Viral testing for pediatric respiratory infections: why precise diagnoses do not always translate to patient benefit. JAMA. 2017; 318:472–3.
42. Brendish NJ, Malachira AK, Armstrong L, Houghton R, Aitken S, Ny-imbili E, et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (Re-sPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med. 2017; 5:401–11.
43. Yum HY, Kim WK, Kim JT, Kim HH, Rha YH, Park YM, et al. The caus-ative organisms of pediatric empyema in Korea. Korean J Pediatr. 2007; 50:33–9.
44. Yoon YK, Park GC, An H, Chun BC, Sohn JW, Kim MJ. Trends of anti-biotic consumption in Korea according to national reimbursement data (2008-2012): a population-based epidemiologic study. Medicine (Balti-more). 2015; 94:e2100.
45. Kang JH, Kim SM, Kim JH, Kyun HJ, Lee KY, Shin YK, et al. Penicillin resistant distribution and in-vitro susceptibility of oral antibiotics against streptococcus pneumoniae, isolated from pediatric patients with com-munity- acquired respiratory infections in Korea. Korean J Pediatr. 2005; 48:40–7.
46. Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, Wang H, et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian network for surveillance of resistant pathogens (ANSORP) study. Antimicrob Agents Chemother. 2012; 56:1418–26.
47. Choi MS, Kim YW, Kim DS, Lee KW. Treatment outcome of penicillin-resistant S. pneumoniae infection. J Korean Pediatr Soc. 2001; 44:149–53.
48. Sung JJ, Kim EJ, Sun YH, Jeon IS, Tchah H, Ryoo E, et al. Clinical pre-sentations of Chlamydia pneumoniae in children hospitalized for acute respiratory infections: a comparison to Mycoplasma pneumonia. Allergy Asthma Respir Dis. 2015; 3:346–51.
49. Yum HY, Choi JY, Rheu JW, Lee KE, Kim CH, Shon MH, et al. Correlation between Chlamydia pneumonia Infection and Childhood Asthma. Pediatr Allergy Respir Dis. 2000; 10:218–24.
50. Meissner HC. Viral bronchiolitis in children. N Engl J Med. 2016; 374:62–72.
51. Choi EH, Lee HJ, Kim SJ, Eun BW, Kim NH, Lee JA, et al. The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005. Clin Infect Dis. 2006; 43:585–92.
52. Kim CK, Choi J, Callaway Z, Kim HB, Chung JY, Koh YY, et al. Clinical and epidemiological comparison of human metapneumovirus and respiratory syncytial virus in Seoul, Korea, 2003-2008. J Korean Med Sci. 2010; 25:342–7.
53. Chung JY, Han TH, Kim BE, Kim CK, Kim SW, Hwang ES. Human metapneumovirus infection in hospitalized children with acute respiratory disease in Korea. J Korean Med Sci. 2006; 21:838–42.
54. Kim YK, Lee HJ. Human metapneumovirus-associated lower respiratory tract infections in korean infants and young children. Pediatr Infect Dis J. 2005; 24:1111–2.
55. Mansbach JM, Piedra PA, Teach SJ, Sullivan AF, Forgey T, Clark S, et al. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med. 2012; 166:700–6.
56. Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet. 2017; 389:211–24.
57. Kim CK, Callaway Z, Koh YY, Kim SH, Fujisawa T. Airway IFN-gamma production during RSV bronchiolitis is associated with eosinophilic inflammation. Lung. 2012; 190:183–8.
58. Chung HL, Park HJ, Kim SY, Kim SG. Age-related difference in immune responses to respiratory syncytial virus infection in young children. Pediatr Allergy Immunol. 2007; 18:94–9.
59. Yoon JS, Kim HH, Lee Y, Lee JS. Cytokine induction by respiratory syncytial virus and adenovirus in bronchial epithelial cells. Pediatr Pulmonol. 2007; 42:277–82.
60. Chung HL, Kim WT, Kim JK, Choi EJ, Lee JH, Lee GH, et al. Relationship between atopic status and nasal interleukin 10 and 11 levels in infants with respiratory syncytial virus bronchiolitis. Ann Allergy Asthma Immunol. 2005; 94:267–72.
61. Chung JY, Han TH, Kim JS, Kim SW, Park CG, Hwang ES. Th1 and Th2 cytokine levels in nasopharyngeal aspirates from children with human bocavirus bronchiolitis. J Clin Virol. 2008; 43:223–5.
62. Choi EH, Lee HJ, Chanock SJ. Human genetics and respiratory syncytial virus disease: current findings and future approaches. Curr Top Microbiol Immunol. 2013; 372:121–37.
63. Choi EH, Lee HJ, Yoo T, Chanock SJ. A common haplotype of interleu-kin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis. 2002; 186:1207–11.
64. Baek YH, Choi EH, Song MS, Pascua PN, Kwon HI, Park SJ, et al. Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea. Arch Virol. 2012; 157:1039–50.
65. Sigurs N, Aljassim F, Kjellman B, Robinson PD, Sigurbergsson F, Bjarna-son R, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010; 65:1045–52.
66. Calışkan M, Bochkov YA, Kreiner-M⊘ller E, B⊘nnelykke K, Stein MM, Du G, et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med. 2013; 368:1398–407.
67. Jung YH, Seo JH, Kim HY, Kwon JW, Kim BJ, Kim HB, et al. The relationship between asthma and bronchiolitis is modified by TLR4, CD14, and IL-13 polymorphisms. Pediatr Pulmonol. 2015; 50:8–16.
68. Chung HL, Lee EJ, Park HJ, Lee KH. Increased epidermal growth factor in nasopharyngeal aspirates from infants with recurrent wheeze. Pediatr Pulmonol. 2015; 50:841–7.
69. Kim BJ, Seo JH, Jung YH, Kim HY, Kwon JW, Kim HB, et al. Air pollu-tion interacts with past episodes of bronchiolitis in the development of asthma. Allergy. 2013; 68:517–23.
70. Lee Chung H, Kim SY, Kim SG. Vascular endothelial growth factor and plasminogen activator inhibitor-1 in children with recurrent early wheeze. J Allergy Clin Immunol. 2007; 119:1541–2.
71. Chung HL, Kim SG. RANTES may be predictive of later recurrent wheezing after respiratory syncytial virus bronchiolitis in infants. Ann Allergy Asthma Immunol. 2002; 88:463–7.
72. Thomsen SF, van der Sluis S, Stensballe LG, Posthuma D, Skytthe A, Kyvik KO, et al. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med. 2009; 179:1091–7.
73. Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadom-ski AM, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014; 134:e1474–502.
74. Yoon JS, Chun YH, Lee JW, Chung NG, Cho B. Value of screening spi-rometry for early diagnosis of bronchiolitis obliterans syndrome in children after allogeneic hematopoietic stem cell transplantation. J Pediatr Hematol Oncol. 2015; 37:e462–7.
75. Moonnumakal SP, Fan LL. Bronchiolitis obliterans in children. Curr Opin Pediatr. 2008; 20:272–8.
76. Jang YY, Park HJ, Chung HL. Serum YKL-40 levels may help distinguish exacerbation of post-infectious bronchiolitis obliterans from acute bron-chiolitis in young children. Eur J Pediatr. 2017; 176:971–8.
77. Lee E, Yoon J, Cho HJ, Hong SJ, Yu J. Respiratory reactance in children aged three to five years with postinfectious bronchiolitis obliterans is higher than in those with asthma. Acta Paediatr. 2017; 106:81–6.
78. Yoon HM, Lee JS, Hwang JY, Cho YA, Yoon HK, Yu J, et al. Post-infectious bronchiolitis obliterans in children: CT features that predict responsiveness to pulse methylprednisolone. Br J Radiol. 2015; 88:20140478.
79. Koh YY, Jung DE, Koh JY, Kim JY, Yoo Y, Kim CK. Bronchoalveolar cel-lularity and interleukin-8 levels in measles bronchiolitis obliterans. Chest. 2007; 131:1454–60.
80. Yoo Y, Yu J, Kim DK, Choi SH, Kim CK, Koh YY. Methacholine and ad-enosine 5'-monophosphate challenges in children with post-infectious bronchiolitis obliterans. Eur Respir J. 2006; 27:36–41.
81. Brower KS, Del Vecchio MT, Aronoff SC. The etiologies of non-CF bron-chiectasis in childhood: a systematic review of 989 subjects. BMC Pediatr. 2014; 14:4.
82. Koh YY, Lee MH, Sun YH, Sung KW, Chae JH. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study. Eur Respir J. 1997; 10:994–9.
83. Kim HY, Kwon JW, Seo J, Song YH, Kim BJ, Yu J, et al. Bronchiectasis in children: 10-year experience at a single institution. Allergy Asthma Immunol Res. 2011; 3:39–45.
84. Hwang EH, Kim HY, Ryu M, Kim SH, Son SK, Kim YM, et al. Clinical characteristics and cause of bronchiectasis in children: review in a center. Allergy Asthma Respir Dis. 2013; 1:383–7.
85. Pizzutto SJ, Hare KM, Upham JW. Bronchiectasis in children: current concepts in immunology and microbiology. Front Pediatr. 2017; 5:123.
86. Shin SA, Yang S, Oh JW, Lee HB, Park CE, Kwan JK. Ultrastructure of nasal cilia in children with recurrent or persistent respiratory diseases. Korean J Pediatr. 2006; 49:410–6.
87. Chi JG, Yoon CJ. Primary Ciliary Dyskinesia(Immotile Cilia Syndrome): Clinical and electron microscopic analysis of 17 cases. Korean J Pathol. 1993; 27:99–107.
88. Moon HR, Ko TS, Ko YY, Choi JH, Kim YC. Cystic fibrosis: a case pre-sented with recurrent bronchiolitis in infancy in a Korean male infant. J Korean Med Sci. 1988; 3:157–62.
89. Ahn KM, Park HY, Lee JH, Lee MG, Kim JH, Kang IJ, et al. Cystic fibro-sis in Korean children: a case report identified by a quantitative pilocar-pine iontophoresis sweat test and genetic analysis. J Korean Med Sci. 2005; 20:153–7.
90. Ahn YM, Choi HR, Lee HJ, Dong ES. A case of congenital central hy-poventilation syndrome (ondine's curse) with hirschsprung's disease. Pediatr Allergy Respir Dis. 1993; 3:113–20.
91. Baek C, Jung JM, Lim YJ, Kim KH, Yu HW, Kim GH, et al. Haddad syndrome with a germ-line mutation in the PHOX2B gene in a Korean Ne-onate. Neonatal Med. 2015; 22:162–7.
92. Ahn YM, Shin HB, Kim EJ. Differences of EEG and sleep structure in pediatric sleep apnea and controls. Sleep Med Psychophysiol. 2008; 15:71–6.
93. Seo HJ, Lee JS, Shin HB, Kim EJ, Shim HJ, Ahn YM. Discrimination between obstructive sleep apnea syndrome and primary snoring in children: comparison of clinical parameters and behavioral disturbance. Korean J Pediatr. 2008; 51:267–75.
94. Jang SJ, Seo HK, Yi SJ, Kim KM, Jee HM, Han MY. Analysis of reports on orphan lung diseases in Korean children. Korean J Pediatr. 2010; 53:711–7.
95. ARDS Definition Task Force. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307:2526–33.
96. Kim SY, Kim YH, Sol IS, Kim MJ, Yoon SH, Kim KW, et al. Application of the Berlin definition in children with acute respiratory distress syndrome. Allergy Asthma Respir Dis. 2016; 4:257–63.
97. Choi SJ, Jeong DS, Oh JW, Lee HB, Kang IJ, Kim KW, et al. A nationwide clinical study of acute respiratory distress syndrome in children. J Korean Pediatr Soc. 1999; 42:23–31.
98. Lee TJ, Kim DS, Shin DH. A Clinical study of the acute respiratory distress syndrome in children. J Korean Pediatr Soc. 2003; 46:42–50.
99. Ko JM, Ha EJ, Lee EH, Lee SY, Kim HB, Hong SJ, et al. Clinical outcome and prognostic factors of acute respiratory distress syndrome in children. Korean J Pediatr. 2005; 48:599–605.
100. Kang SS, Pae RM, Lee EK, Bang KW, Kim HS, Chun YH, et al. Outcome of acute respiratory distress syndrome in children: a single center study. Allergy Asthma Respir Dis. 2014; 2:266–71.
Fig. 1.
Number of studies published in PubMed or KoreaMed on pathogens of childhood respiratory diseases in Korean childrenduring the past 30 years. S. pneumonia, Streptococcus pneumoniae; M. pneumonia, Mycoplasma pneumoniae; RSV, respiratory syncytial virus; M. tuberculosis, Mycobacterium tuberculosis; H. influenzae, Hemophilus influenzae.
Fig. 2.
Number of studies worldwide on particulate matter (PM) published in PubMed during the past 30 years.
Table 1.
Number of studies on Korean childhood respiratory diseases published in PubMed and KoreaMed during the past 30 years
XML Download